Kyowa Kirin is a fast-growing global specialty pharmaceutical company that applies state-of-the-art biotechnologies to discover and deliver novel medicines in four disease areas: bone and mineral; intractable hematologic; hematology oncology; and rare disease. A Japan-based company, our goal is to translate science into smiles by delivering therapies where no adequate treatments currently exist, working from drug discovery to product development and commercialization. In North America, we are headquartered in Princeton, NJ, with offices in California, North Carolina, and Mississauga, Ontario. The Senior Medical Director, Early Clinical Development Lead, Global Hematology/Oncology plays a critical role in advancing innovative therapeutics within Hematology/Oncology. This position demands deep expertise across the global drug development continuum-from early discovery through go/no decisions and understanding late-stage clinical trials. This position provides strategic direction and long-term guidance on all clinical aspects, including first-in-human, dose-escalation, proof-of-concept, and Phase I-III trials. In close collaboration with Strategic Functions, Project Leaders and Clinical Science, this role is responsible for shaping and executing comprehensive early clinical development strategies, ensuring alignment with Target Medicine Profiles (TMPs) and Integrated Evidence Plans (IEPs) across all phases of development.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Industry
Chemical Manufacturing
Education Level
Ph.D. or professional degree
Number of Employees
5,001-10,000 employees